During early mouse embryogenesis, fetal liver kinase (Flk)-1, a receptor for vascular endothelial growth factor, and Runx1, a runt domain transcription factor, have prerequisite roles in the generation of hematopoietic lineages. Flk-1 expression is maintained in successive stages from mesoderm to endothelial cells and is These results provide novel insight into the role of Runx1 during the development of hematopoietic cell lineages.
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Introduction
During mammalian embryogenesis, two waves of hematopoiesis develop in close association with the development of endothelial cells (ECs). The first wave, known as primitive hematopoiesis, occurs transiently in association with the formation of extraembryonic tissue structures called blood islands that consist of blood cells and surrounding angioblasts. The second wave is known as definitive hematopoiesis, during which the hematopoietic stem cells that function throughout life are generated.
Accumulating evidence suggests that at least a part of the definitive hematopoietic cells (HPCs) are generated from a special subset of ECs 1,2 designated hemogenic ECs. This notion was first suggested by histologic observations in many species of clusters of blood cells attached to the luminal wall of the dorsal aorta at the onset of definitive hematopoiesis that appeared to be budding from the ECs [3] [4] [5] [6] [7] . More recently, the existence of hemogenic ECs was demonstrated in experiments in which multilineage HPCs including lymphocytes were induced from cells that were sorted from embryos according to their expression of EC markers [8] [9] [10] [11] [12] .
Fetal liver kinase-1 (Flk-1), also known as vascular endothelial growth factor (VEGF) receptor-2, is a receptor tyrosine kinase that is indispensable for differentiation of HPCs and ECs 13, 14 . Its expression is detected during successive stages from early lateral mesoderm cells to ECs 15, 16 . Previously, we and others demonstrated that early Flk-1-expressing cells are the diverging point between HPCs (both the primitive and definitive) and ECs 16, 17 Figure 1B ). Single-copy integration of the vector DNA to the clones and the integrity of the targeted Runx1 locus were confirmed by Southern blot analysis with an internal genomic probe spanning Runx1 P2 -5'UTR and the adjacent coding region.
Materials and Methods

Construction of the
The floxed insert cassette was removed from correctly-targeted ES clones by transient
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Plasmids and transient transfections
The pFlk-1prom/GL3 vector was generated by insertion of the -640bp/+299bp promoter fragment of the pGLacZ-Flk-1 promoter/enhancer 25 Luciferase activity was normalized for transfection efficiency with the co-transfected 100 ng pRL-null (Promega) as previously described 28 . Luciferase assays were 7 performed 48 hours after transfection using the dual luciferase reporter assay system (Promega) according to the manufacturer's protocols. All trans-activation experiments were repeated at least three times.
ES lines with conditional Runx1 expression
The modified version of the tetracycline (Tet) regulatory system was used to induce Runx1 expression in ES cell clones essentially as described previously 29 
Cell culture and in vitro differentiation of ES cells
Culture of ES cells and OP9 stromal cells was performed as previously described 10, 22 . Induction of ES cell differentiation was also performed as described previously 10, 22 . Briefly, 3x10 4 
Monoclonal antibodies (MoAbs), cell staining, and sorting
The MoAb AVAS12 (anti Flk-1) was purified from hybridoma culture supernatants using protein G-sepharose columns (Pharmacia, Uppsala, Sweden) and labeled with allophycocyanin (APC) by standard methods 15 . Fluorescein isothiocyanate-anti-CD45
(common leukocyte antigen) and fluorescein isothiocyanate-anti-Ter119 (erythroid
monocyte/macrophage marker), APC-anti-Ly6G/C (Gr-1, granulocyte marker), and APC-anti-CD45R (B220, B-cell marker) were purchased from Pharmingen (Pharmingen, San Diego, CA ). Nonspecific antibody binding was blocked using normal 
Immunoblotting
Runx1 proteins were detected with rabbit polyclonal serum against Runx1 (Oncogene, Parmastadt, Germany) followed by treatment with a horseradish peroxidase-conjugated anti-rabbit IgG secondary antibody.
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was prepared from sorted cell populations or cultured cells using ISOGEN (Nippon Gene, Toyama, Japan). RNA was reverse-transcribed with Superscript II reverse transcriptase (GIBCO BRL) and oligo (dT) [12] [13] [14] [15] [16] [17] [18] 
Results
Establishment of Runx1-Venus knock -in ES cell lines.
First, we investigated the relation between Runx1 and Flk-1 expression during HPC became dominant within the Runx1-Venus + cells (11.1% versus 3.5%, respectively).
Considering that Runx1 is a requisite molecule for the differentiation of ECs to HPCs, these data suggest a sequence of events in which Runx1 begins to be expressed in a portion of Flk-1 + cells, which in turn triggers downregulation of Flk-1 and initiates transition to hematopoietic specification.
For Figure 4A ). In contrast, Runx1 had no effect on the promoter of elongation factor-1 (EF-1). Runx1-dependent repression of the Flk-1 promoter is EC-specific, as we could not detect the negative regulatory effects of Runx1 on the To determine which Runx1 domain is required for this repression, we examined Runx1 deletion mutants in our assay ( Figure 5A ). The amino acids 242-371 were important for this inhibitory effect of Runx1 ( Figure 5B ). When we transfected BAEC For personal use only. on December 14, 2017. by guest www.bloodjournal.org From with the Runx1 mutant K83E, which maintains the ability to heterodimerize with the β−subunit but loses the DNA-binding ability 27 , the Flk-1 promoter activity was not suppressed. Taken together, these data strongly suggest that Runx1 has negative regulatory effects on Flk-1 promoter activity in ECs and this repression requires intact DNA-binding and transactivating domains of Runx1 protein.
Overexpression of Runx1 inhibits Flk-1 expression during in vitro differentiation of ES cells
We next investigated whether Runx1-dependent repression of Flk-1 is observed not only in EC lines, but also or in the ES cell differentiation culture. For this purpose, we 
Discussion
During the EC-to-HPC transition, molecules determining the essential features of ECs as an integral part of the endothelial sheet are downregulated while at the same time HPC features are acquired. The budding of HPCs from the dorsal aorta, which regularly occurs in normal embryos is not detectable in Runx1 null-mutant mice 21 and no hemogenic ECs are detected in the embryonic vessels of the mutant mice 11 . These studies strongly suggest that Runx1 is directly involved in the EC-to-HPC transition.
The aim of this study was to dissect this process, with particular focus on the relation between Runx1 and Flk-1.
Under OP9 stromal cell culture conditions, which preferentially support the differentiation of ES cells to a mesodermal lineage, Runx1 is induced mostly within the Flk-1 is a VEGF receptor that has a central role in endothelial development 13, 14 .
VEGF-Flk-1 signaling mediates proliferation, migration, and other EC-specific In chicken, a higher concentration of VEGF inhibits the differentiation of HPCs from VEGF-R2 + cells 42 . These data indicate that precise regulation of VEGF signaling is necessary not only for EC development, but also for proper HPC development. In this study, we demonstrated that the Runx1 The Runx family of transcription factors acts as both transcription activators and a transcriptional repressors or silencers, which depends both on the cellular context and target molecules. The mechanisms of repression by the Runx family have been studied in detail 43 . The recruitment of co-repressors, including mSin3A, TLE, SUV39H1, and histone deacetylase, is also involved in Runx1-mediated repression [43] [44] [45] [46] [47] . In our study, disruption of the VWRPY motif had little impact on the repression, suggesting that TLE is not involved in this effect (αB1 (1-371) deletion mutant, Figure 5 ). Although our results with the Runx1 K83E mutant clearly showed involvement of DNA binding in the inhibitory function of Runx1, we could not determine the elements in Flk-1 promoter responsible for the repression in a reporter assay, suggesting Runx1 transcription factor 
FACS analysis of Venus knock-in ES cells differentiating on OP9 stromal cells. (A)
Runx1
Venus/+ ES cells were cultured on OP9 cells and analyzed for the expression of For personal use only. on December 14, 2017. by guest www.bloodjournal.org From
